Abstract: A securement assembly for supporting and stabilizing a vascular access device, such as a tunneled central venous access devices (CVAD) or a surgical drain, is provided herein. The securement assembly may comprise a base and a lid. The base may include a central post about/around which the external portion of the access device or surgical drain may be wrapped. The lid may extend from the base and may be configured to cover the external portion of the access device or surgical drain (when installed). In various embodiments, the base and the lid collectively define an annular chamber around the central post of the base.

Abstract: A securement assembly for supporting and stabilizing a vascular access device, such as a tunneled central venous access devices (CVAD) or a surgical drain, is provided herein. The securement assembly may comprise a base and a lid. The base may include a central post about/around which the external portion of the access device or surgical drain may be wrapped. The lid may extend from the base and may be configured to cover the external portion of the access device or surgical drain (when installed). In various embodiments, the base and the lid collectively define an annular chamber around the central post of the base.

Abstract: The present invention relates to novel benzopyran ER-? agonist compounds, pharmaceutical compositions thereof, and use of these compounds to treat a ER-? mediated disease such as nocturia, obstructive uropathy, benign prostatic hypertrophy, obesity, dementia, hypertension, incontinence, colon cancer, prostate cancer, infertility, depression, leukemia, inflammatory, bowel disease, and arthritis. Formula (I), wherein G is —O—, —S(O)—, —CF2—, —C(O)—, —CR1H— or —CR2(OH)—; R is halo, (C1-C4)alkyl or R2—(CH2)m—; R1 is F, hydroxyl, cyano, trifluoromethyl, (C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkycarbonyloxy or benzyl; R2 is trifluoromethyl or (C1-C4)alkyl; R3 is cyano, hydroxyl, (C2-C4)alkenyl, (C1-C4)alkoxy or (C1-C4)alkoxycarbonyl; n is 0, 1 or 2; and m is 0, 1 or 2; and pharmaceutically acceptable salts thereof.

Abstract: This invention relates to novel heterocycles which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), also referred to as 11CBy, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines.

Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor ? agonists. Such agonists are useful for the treating Estrogen Receptor ? mediated diseases such as prostate cancer or BPH.